Updates: CDC Grand jury investigation and CDC’s ACIP meeting

The CDC’s Advisory Committee on Immunization Practices (ACIP) met June 21 and 22 and will meet again June 23. But before we update you on what’s in the immunization pipeline, let’s talk about the CDC grand jury investigation.

A court case demanding that a grand jury look at the actions of the CDC since 2020 is currently in the hands of the 9th Circuit Court of Appeals. Not surprisingly, the federal government has made typical legal maneuvers aimed at getting the plaintiffs thrown out of court on legal technicalities before a judge will even look at the merits of their claims.

Soon, the 9th Circuit will make a ruling on whether the plaintiffs, Senators Kim Thatcher and Dennis Linthicum from Oregon, along with Dr. Henry Ealy and others, have legal legs to stand on. The plaintiffs must file a brief explaining to the court why the federal government is wrong and convince them of a strong, valid reason to be in court. That filing is due July 10, 2023.

You can help. One simple signature can help get this movement to the tipping point. As of this writing, the petition has 270,000 signatures. The more signatures it has, the more weight the petition will carry with the court.

Help the team get the petition over 300,000 signatures to show the court how many Americans are watching and demanding justice. Once filed, the petition will become part of the court record that will be transmitted to the U.S. Supreme Court if an appeal is made and heard.

Click the video to hear from Dr. Ealy and the senators about where things currently stand and to learn of the impact your simple signature can make.

Please sign the petition to investigate the CDC if you haven’t already. Send it to your friends. Post it on your social media.

The CDC’s vaccine recommendation pipeline: ACIP recap

The CDC is currently focused on the recommended immunization schedules, echoing the cries of the World Health Organization to have children and adults “catch up” with schedules after a significant plummet in overall vaccine rates since the pandemic was declared. With the potential that more emergencies could be declared (and multiply if the pandemic treaty and IHR Amendments pass in 2024), manufacturers are lining up to get in the pipeline for vaccines with liability-free sales — and free government marketing to boot. At recent meetings of the ACIP, the overall theme of the conversation has shifted from whether vaccines are safe and effective enough to be recommended to creating a “simplified” recommendation that will be easy to implement.